Free Newsletter
PAREXEL develops cold-chain data system
Global contract researcher PAREXEL has stepped into the cold chain business. The company has unveiled an integrated study-drug transport system for temperature monitoring based on radio-frequency identification technology.
The system is part of the company's clinical logistics service offering and PAREXEL says it shaves a day off the time required for investigators to begin using experimental drugs in clinical trials.
Traditional methods involve the shipment of temperature-monitoring devices and their return to a hub for analysis before study drugs can be OK'd for use. The CRO's system, however, incorporates an RFID/sensor chip for en route temperature recording and a mobile phone in the drug packaging for the collection and transmission of temperature data. The system checks temperature at pre-set times during shipment. At the clinic, staffers access the RFID data and transmit it to a hub for review. If the temperature stays in range during transport, clinicians are given the green light to release the drug for use in the trial.
- see the Parexel announcement
Related Articles:
RFID helps Medlog manage cold-chain shipments
Cold-chain solutions a must by 2014
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: